Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Dulucq S, Rigal-Huguet F, Nicolini FE, Cony-Makhoul P, et al. Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study. Br J Haematol 2023;201:1116-1124.
PMID: 37004981


Privacy Policy